Adherence with tobramycin inhaled solution and health care utilization
Tóm tắt
Từ khóa
Tài liệu tham khảo
Cystic Fibrosis Foundation: Patient Registry: Annual Data Report 2007. 2008, Bethesda, MD
Accurso FJ: Pulmonary and Critical Care Updates: Update in Cystic Fibrosis 2007. Am J Respir Crit Care Med. 2008, 177: 1058-1061. 10.1164/rccm.200801-069UP.
Modi AC, Lim CS, Yu N, Geller D, Wagner MH, Quittner AL: A multi-method assessment of treatment adherence for children with cystic fibrosis. J Cyst Fibros. 2006, 5: 177-185. 10.1016/j.jcf.2006.03.002.
DiMatteo MR: Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004, 42: 200-209. 10.1097/01.mlr.0000114908.90348.f9.
Quittner AL, Barker DH, Marciel KK, Grimley ME: Cystic fibrosis: A model for drug discovery and patient care. 2009, NY: Guilford Press, 4
Cystic Fibrosis Foundation: Patients Registry: 2005 Annual Data Report. 2006, Bethesda, MD: Cystic Fibrosis Foundation
Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL: Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002, 34: 91-100. 10.1002/ppul.10127.
Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K: Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr. 2001, 138: 699-704. 10.1067/mpd.2001.112897.
Flume PA, O'Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ, Willey-Courand DB, Bujan J, Finder J, Lester M, Quittell L, et al: Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2007, 176: 957-969. 10.1164/rccm.200705-664OC.
Zindani G, Streetman D, Streetman D, Nasr S: Adherence to treatment in children and adolescent patiens with cystic fibrosis. J Adolesc Health. 2006, 38: 13-17. 10.1016/j.jadohealth.2004.09.013.
Suri R, Wallis C, Bush A, et al: A comparitive study of hypertonic saline, daily and alternate-day rhDNase in children with cystic fibrosis. Health Technol Assess. 2002, 6: 1-60.
Merlo CA, Boyle MP, Diener-West M, Marshall BC, Goss CH, Lechtzin N: Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis. Chest. 2007, 132: 562-568. 10.1378/chest.06-2888.
Moskowitz S, Silva S, Mayer-Hamblett N, Pasta D, Mink D, Wagener S, Kostan M, Morgan W: Inhaled Antibiotic Use Among North American Cystic Fibrosis Patients. Annual Meeting of American Thorasic Society. 2007
Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D: Cystic fibrosis adult care: consensus conference report. Chest. 2004, 125: 1S-39S. 10.1378/chest.125.1_suppl.1S.
Adamson D, Chang S, Hansen L: Health research data for the real world: The MarketScan databases, in White Paper. 2005, Ann Arbor, MI: Thomson Medstat
MarketScan Research Databases User Guide and Database Dictionary. 2006, Ann Arbor, MI: Thomson Medstat
Rector TS, Wickstrom SL, Shah M, Thomas Greeenlee N, Rheault P, Rogowski J, Freedman V, Adams J, Escarce JJ: Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions. Health Serv Res. 2004, 39: 1839-1857. 10.1111/j.1475-6773.2004.00321.x.
Consumer Price Indexes. [ http://www.bls.gov/cpi/ ]
Ash A, Ellis RP, Pope G, Ayanian J, Bates D, Burstin H, Iezzoni L, McKay E, Yu W: Using Diagnoses to Describe Populations and Predict Costs. Health Care Financ Rev. 2000, 21: 7-28.
Petersen LA, Pietz K, Woodard LD, Byrne M: Comparison of the predictive validity of diagnosis-based risk adjusters for clinical outcomes. Med Care. 2005, 43: 61-67.
Briesacher BA, Sacco P, Fouayzi H, Quittner A: Tobramycin inhaled solution utilization in cystic fibrosis patients in a privately insured US population. 2009, Toronto
Cystic Fibrosis Foundation: Patient Registry 2001 and 2006 Annual Data Report. 2007, Bethesda, MA
Moskowitz SM, Silva SJ, Mayer-Hamblett N, Pasta DJ, Mink DR, Mabie JA, Konstan MW, Wagener JS: Shifting patterns of inhaled antibiotic use in cystic fibrosis. Pediatric Pulmonology. 2008, 43: 874-881. 10.1002/ppul.20873.
Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, Vasiljev KM, Borowitz D, Bowman CM, Marshall BC, et al: Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med. 1999, 340: 23-30. 10.1056/NEJM199901073400104.
Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, Canning C, Platt R: Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999, 37: 846-857. 10.1097/00005650-199909000-00002.